News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,122 Results
Type
Article (88051)
Company Profile (825)
Press Release (782225)
Multimedia
Podcasts (199)
Webinars (29)
Section
Business (233303)
Career Advice (4148)
Deals (39886)
Drug Delivery (151)
Drug Development (91445)
Employer Resources (205)
FDA (18405)
Job Trends (17432)
News (397998)
Policy (39976)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (152)
Alliances (56982)
ALS (183)
Alzheimer's disease (1806)
Antibody-drug conjugate (ADC) (352)
Approvals (18588)
Artificial intelligence (643)
Autoimmune disease (175)
Automation (40)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (490)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (673)
Cancer (5116)
Cardiovascular disease (454)
Career advice (3572)
Career pathing (41)
CAR-T (311)
CDC (59)
Celiac Disease (2)
Cell therapy (850)
Cervical cancer (38)
Clinical research (77144)
Collaboration (1866)
Company closure (5)
Compensation (1189)
Complete response letters (74)
COVID-19 (2996)
CRISPR (99)
C-suite (901)
Cystic fibrosis (155)
Data (6378)
Decentralized trials (2)
Denatured (73)
Depression (153)
Diabetes (541)
Diagnostics (7255)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (314)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (245)
Earnings (100285)
Editorial (65)
Employer branding (25)
Employer resources (174)
Events (135268)
Executive appointments (1043)
FDA (21647)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1584)
Gene editing (218)
Generative AI (68)
Gene therapy (687)
GLP-1 (1145)
Government (5455)
Grass and pollen (8)
Guidances (387)
Healthcare (20957)
HIV (65)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (300)
Immuno-oncology (65)
Indications (107)
Infectious disease (3290)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (124)
Intellectual property (255)
Interviews (816)
IPO (17966)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (71)
Kidney cancer (17)
Labor market (94)
Layoffs (660)
Leadership (40)
Legal (10162)
Liver cancer (99)
Longevity (16)
Lung cancer (689)
Lymphoma (385)
Machine learning (45)
Management (66)
Manufacturing (879)
MASH (176)
Medical device (15053)
Medtech (15110)
Mergers & acquisitions (23009)
Metabolic disorders (1431)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (364)
Neuropsychiatric disorders (104)
Neuroscience (3158)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5114)
Now hiring (67)
Obesity (697)
Opinion (337)
Ovarian cancer (170)
Pain (218)
Pancreatic cancer (234)
Parkinson's disease (303)
Partnered (39)
Patents (517)
Patient recruitment (502)
Peanut (61)
People (66987)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23839)
Phase 2 (33479)
Phase 3 (25212)
Pipeline (5357)
Policy (341)
Postmarket research (3554)
Preclinical (10700)
Press Release (72)
Prostate cancer (253)
Psychedelics (58)
Radiopharmaceuticals (304)
Rare diseases (940)
Real estate (7442)
Recruiting (81)
Regulatory (29129)
Reports (68)
Research institute (2731)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (262)
Series B (204)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1161)
Venture capital (99)
Weight loss (480)
Women's health (94)
Worklife (22)
Date
Today (155)
Last 7 days (670)
Last 30 days (2417)
Last 365 days (32893)
2026 (3433)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (347)
Arkansas (14)
Asia (51613)
Australia (9064)
California (11717)
Canada (3365)
China (1195)
Colorado (500)
Connecticut (508)
Delaware (352)
Europe (118599)
Florida (1722)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (975)
India (72)
Indiana (550)
Iowa (24)
Japan (442)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1469)
Massachusetts (8625)
Michigan (364)
Minnesota (669)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3146)
New Mexico (33)
New York (3092)
North Carolina (1631)
North Dakota (10)
Northern California (5627)
Ohio (359)
Oklahoma (23)
Oregon (55)
Pennsylvania (2339)
Puerto Rico (24)
Rhode Island (50)
South America (1664)
South Carolina (67)
South Dakota (1)
Southern California (4524)
Tennessee (178)
Texas (1852)
United States (42246)
Utah (352)
Vermont (1)
Virginia (294)
Washington D.C. (88)
Washington State (986)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
There are 871,122 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
FDA Refuses To Review Moderna’s mRNA Flu Vaccine, Claims Trial Inadequacies
After receiving a letter directly from CBER Director Vinay Prasad, Moderna said the FDA had previously signed off on the use of a licensed flu vaccine as a comparator for a Phase 3 study of mRNA-1010.
February 11, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs
February 11, 2026
·
10 min read
Press Releases
HepaRegeniX Completes Phase Ib Study of HRX-215 to Enhance Liver Regeneration in Patients Undergoing Minor Liver Resection
February 11, 2026
·
4 min read
Press Releases
Helsinn and MagnaPharm enter long-term agreement for AKYNZEO® and ALOXI® across five Central and Eastern European countries
February 11, 2026
·
4 min read
Press Releases
Akeso’s IL-4Rα/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications
February 11, 2026
·
5 min read
Press Releases
Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board
February 11, 2026
·
5 min read
Press Releases
PL BioScience Wins Regulatory Certification from Japan’s PMDA
February 11, 2026
·
3 min read
Press Releases
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments
February 11, 2026
·
7 min read
Press Releases
Galderma Expands Restylane® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™
February 11, 2026
·
7 min read
Press Releases
PharmaResearch Announces Supply Agreement for Rejuran in Brazil
February 11, 2026
·
2 min read
1 of 87,113
Next
